Annandale Capital, LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1811739 DALLAS, TX

Position in TMO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,733,414

+$545,123 QoQ

Shares Held

5,452

+22.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.82%

of 13F equity value

Holder Rank

#1,051

of 2,606 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Annandale Capital, LLC holds $6,095,710 across 4 Diagnostics & Research names. TMO ranks #1 (44.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc. This page	5,452	$2,733,414
2	DHR	Danaher Corp /De/	7,827	$1,490,886
3	IQV	Iqvia Holdings Inc.	5,300	$1,024,066
4	MEDP	Medpace Holdings, Inc.	1,600	$847,344

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,733,414	5,452	+22.5%	Shares	Sole	2026-08-13
2026-03-31	$2,188,291	4,452	+29.1%	Shares	Sole	2026-05-15
2025-12-31	$1,997,943	3,448	0.0%	Shares	Sole	2026-02-12
2025-09-30	$16,723	3,448	+48.2%	Shares	Sole	2025-11-13
2025-06-30	$943,505	2,327	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.